Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Biomimetic collagen-based scaffolds for the study of pancreatic cancer and delivery anti-tumoural miRNA for enhanced cancer therapy.

Descrizione del progetto

Un modello 3D per la terapia mirata del cancro pancreatico

La matrice extracellulare tumorale è una complessa rete di proteine e glicoproteine che offre supporto strutturale e promuove la crescita del tumore. Le alterazioni a tale struttura possono influenzare il comportamento del cancro, compresa l’invasione e la resistenza alla terapia; di conseguenza, imitarla in modo preciso risulta fondamentale per comprendere la trasformazione maligna. Con il sostegno del programma di azioni Marie Skłodowska-Curie, il progetto PancmiR si propone di creare un modello di cancro pancreatico in 3D e di replicare la matrice extracellulare tumorale attraverso un’impalcatura a base di collagene. Lo studio si concentrerà sull’oncogene KRAS, che subisce frequenti mutazioni nel cancro al pancreas; inoltre, i ricercatori verificheranno la validità della somministrazione di microRNA specifici per la sottoregolazione di KRAS in qualità di strategia terapeutica.

Obiettivo

Pancreatic tumours are among the most aggressive, and are associated with the lowest survival rates. The main reason of this is their characteristic dense fibrotic stroma, which creates a perfect environment to promote cancer progression. To accurately mimic the Extracellular Matrix (ECM) is challenging, but is essential to understanding the interaction that occurs during malignant transformation. KRAS mutation is the most frequent alteration in pancreatic cancer. Micro(mi)RNA-143-3p and miRNA-216b have been shown to decrease KRAS gene expression and suppress tumour cell growth. My overarching Aim is to generate a 3D model of pancreatic cancer in which I can test the ability of a miRNA-activated scaffold to suppress tumour growth and facilitate local delivery of miRNA (miRNA-143-3p and miRNA-216b) that downregulate KRAS expression. Prof. Fergal O’Brien’s group in Royal College of Surgeon in Ireland has an extensive experience with development of biomimetic scaffolds to recreate the tumoural ECM and activating scaffolds to release therapeutic molecules (e.g. miRNAs). Using techniques established in his group, I will develop a 3D collagen-based scaffold that recreates the structure of pancreatic tumour ECM and then utilise this form as miRNA-activated scaffolds that will be used as local delivery systems in a radical new treatment for this disease. I will be supervised by Prof. O’Brien, and he will guide my Career Development Plan. I will develop complementary skills in project management, leadership, entrepreneurship, commercialisation, dissemination, and profile enhancement. Acquiring advanced research competences and complementary skills, I will maturate as an independent scientist, enhancing my professional visibility, capacity, and competitiveness in the field of biomaterials. This Fellowship will significantly contribute to the achievement of my long-term career goal, which is becoming an independent scientist leading my own biomaterials research group.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2023-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

ROYAL COLLEGE OF SURGEONS IN IRELAND
Contributo netto dell'UE
€ 199 694,40
Indirizzo
ST STEPHEN GREER 123
D02 YN77 DUBLIN 2
Irlanda
Regione
Ireland Eastern and Midland Dublin
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato